A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma
Sponsor: Shin Kong Wu Ho-Su Memorial Hospital
Terminated
Most patients completed only the primary objective (PET) and not went throught the secondary outcome (efficacy phase) of 8wks period.
Other terminated trials from Shin Kong Wu Ho-Su Memorial Hospital
- Lumbar Spinal Stenosis · Phase NA · Dec 2019
- Lumbar Disc Herniation · Phase NA · Dec 2019
- Chronic Low Back Pain · Phase PHASE4 · Dec 2014
See all terminations from Shin Kong Wu Ho-Su Memorial Hospital
Other Sarcoma trials with similar outcome
This PHASE2 trial investigates Sarcoma and is currently terminated or withdrawn. Shin Kong Wu Ho-Su Memorial Hospital leads this study, which shows 11 recorded versions since 2012 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2
-
Dec 2021 — Dec 2022 [monthly]
Terminated PHASE2
▶ Show 6 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE2
-
Jun 2018 — Nov 2020 [monthly]
Terminated PHASE2
-
May 2018 — Jun 2018 [monthly]
Terminated PHASE2
-
Aug 2017 — May 2018 [monthly]
Terminated PHASE2
-
Jan 2017 — Aug 2017 [monthly]
Terminated PHASE2
First recorded
Aug 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Shin Kong Wu Ho-Su Memorial Hospital
For direct contact, visit the study record on ClinicalTrials.gov .